Zur Rose Group AG (SWX: ROSE) Stock Analysis & Fundamentals | ScreenerHero

Create free account

ROSEZur Rose Group AG

SWX · CH · Healthcare · Drug Manufacturers - General

9.100CHF-0.33%Mkt Cap: —P/E: —4d ago

Industry Peers

Drug Manufacturers - General

vs Drug Manufacturers - General

1M Perf

Lower

Eli Lilly and Company

$1.08TUSDP/E 43.1

Johnson & Johnson

$633.19BUSDP/E 30.5

$461.26BUSDP/E 128.0

Roche Holding AG

$314.36BUSDP/E 21.6

Merck & Co., Inc.

$319.99BUSDP/E 36.5

Roche Holding AG

$292.66BUSDP/E 20.1

$284.58BUSDP/E 22.8

$278.57BUSDP/E 22.6

AstraZeneca PLC

$276.37BUSDP/E 28.8

AstraZeneca PLC

$287.55BUSDP/E 28.7

Novo Nordisk A/S

$210.73BUSDP/E 11.9

$201.93BUSDP/E 26.0

Gilead Sciences, Inc.

$162.98BUSDP/E 17.9

$138.61BUSDP/E 18.6

Bristol-Myers Squibb Company

$118.71BUSDP/E 16.3

GlaxoSmithKline plc

$103.52BUSDP/E 14.2

$98.63BUSDP/E 19.1

Bayer Aktiengesellschaft

$31.91BUSDP/E 23.3

Nuvo Pharmaceuticals Inc.

$26.62BUSDP/E 10.1

Recordati Industria Chimica e Farmaceutica S.p.A.

$11.36BUSDP/E 22.8

Orion Oyj Class B

$11.03BUSDP/E 19.1

Orion Oyj Class B

$10.98BUSDP/E 19.1

$6.72BUSDP/E 14.9

Organon & Co. Common Stock

$3.56BUSDP/E 14.6

$3.02BUSDP/E 18.4

Scilex Holding Company Common Stock

MIRA Pharmaceuticals Inc. Common Stock

Flexion Therapeutics, Inc.

Bristol-Myers Squibb Company

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit247.14M $

Net Income (TTM)-111.00M $

Revenue/Share—

Last Price9.100 CHF

Fiscal Year End—

MR Quarter—

Employees—

CountryCH

SectorHealthcare

IndustryDrug Manufacturers - General

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-8.65

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B—

EPS (TTM)—

EPS (Forward)—

52W Range

3.92295% of range9.350

52W High9.350 CHF

52W Low3.922 CHF

Profitability

Gross Margin21.29%

Oper. Margin—

EBITDA Margin—

Profit Margin-9.56%

ROE-28.59%

ROA-12.50%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-30.36M $

CapEx (TTM)32.65M $

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.92

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CHF

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Technical

SMA 5039.71 (-77.1%)

SMA 20037.61 (-75.8%)

Beta—

S&P 52W Chg—

Avg Vol (30d)304.48K

Avg Vol (10d)75.67K

Technical Indicators

RSI (14)73.9

MACD0.4703

MACD Signal0.3853

MACD Hist.+0.0849

BB Upper9.243 CHF

BB Middle8.050 CHF

BB Lower6.857 CHF

BB Width29.65%

ATR (14)0.4766 CHF

Vol Ratio (20d)0.57x